Country for PR: United Kingdom
Contributor: PR Newswire Europe
Tuesday, November 10 2020 - 22:46
AsiaNet
German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container
BITTERFELD-WOLFEN, Germany, Nov. 10, 2020 /PRNewswire-AsiaNet/ --

·  Transport and storage of up to 1,000,000 vaccination doses with low 
temperatures down to -80 degrees C/-112 degrees F
·  Active deep cooling technology ensures safe and controlled transport and 
storage 


Vaccine manufacturers, transport and storage providers are facing major 
challenges in the fight against the coronavirus. MECOTEC Group has announced a 
complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport 
+ 3. Storage & distribution of the vaccines: Immediately after production, the 
vaccine is frozen in a deep cold storage and then loaded into a container, 
transported afterwards safely to the distribution center at constant 
temperatures down to - 80 degreesC / -112 degrees F. On site, the transport 
container then functions as a storage and distribution center. It is supplied 
via a three-phase power connection with 400V. 

"Our many years of experience in the field of cooling technology made it 
possible within a very short timeframe to develop the transport, storage and 
distribution container," explains Jan Hüneburg, Managing Director at COOLANT, 
the industrial division of MECOTEC.

"We are pleased that today we can present our Mobile Hybrid Container Solution 
for the transport and storage of Covid-19-Vaccines globally," states the CEO of 
MECOTEC Group Enrico Klauer. "Since our system is based on an active deep 
freezing technology, it does not require dry ice for cooling which makes it 
also suitable for safe carriage by air."

The complete solution developed by the MECOTEC Group can be used worldwide. "It 
is our aim to get the vaccine to the people as soon as possible. Therefore we 
offer several options: Orders for container production can be placed at MECOTEC 
directly and at our worldwide sales offices. In addition we also offer licensed 
production," says Klauer.

Full press release: 
https://www.mecotec.net/en/first-mobile-hybrid-container-solution-for-covid-19-vaccines/


Dr. Karin Funke-Rapp 
karin@funke-rapp.com 
Tel.: +49 176/62755085

Photo - 
https://mma.prnewswire.com/media/1331027/MECOTEC_Hybrid_Container_Solution.jpg 
Photo - https://mma.prnewswire.com/media/1331026/MECOTEC_COVID_19_Vaccines.jpg
 
Source: MECOTEC GmbH